Assertion: methylphenidate | /r/HasProperty | contraindicated
Facets:
value: for individuals
type: TRANSITIVE-OBJECT
value: because of possible hypertensive crisis
type: CAUSE
value: within the preceding 2 weeks
type: TEMPORAL
value: in patients
type: LOCATION
value: in patients with high blood pressure
type: OTHER
value: with mao-inhibitors
type: OTHER
Source sentences:
text: Methylphenidate is contraindicated for individuals using monoamine oxidase inhibitors (e.g., phenelzine, and tranylcypromine), or individuals with agitation, tics, glaucoma, or a hypersensitivity to any ingredients contained in methylphenidate pharmaceuticals.
text: Methylphenidate is contraindicated for individuals using monoamine oxidase inhibitors (e.g., phenelzine, and tranylcypromine), or individuals with agitation, tics, glaucoma, or a hypersensitivity to any ingredients contained in methylphenidate pharmaceuticals.
text: Because of possible hypertensive crisis, methylphenidate is contraindicated in patients being treated (currently or within the preceding 2 weeks) with MAO-inhibitors (see section 4.3 Contraindications).
text: Methylphenidate is contraindicated for individuals using monoamine oxidase inhibitors (e.g., phenelzine, and tranylcypromine), or individuals with agitation, tics, glaucoma, or a hypersensitivity to any ingredients contained in methylphenidate pharmaceuticals.
text: Methylphenidate is contraindicated in patients with glaucoma, severe anxiety and tension, personal history of tics, Tourette ’s syndrome and agitation.
text: Methylphenidate is contraindicated in patients with high blood pressure, congenital heart problems, angina, history of drug/alcohol addiction, GI disorders, suicidal thoughts, psychosis, bipolar disorders, heart rhythm disorders and depressive disorders.
text: Because of possible hypertensive crisis, methylphenidate is contraindicated in patients being treated (ongoing treatment or received during the last 14 days) with non-selective, irreversible MAO-inhibitors (see section 4.3).
text: Methylphenidate is contraindicated for individuals using monoamine oxidase inhibitors (e.g., phenelzine and tranylcypromine), or individuals with agitation, tics, or glaucoma, or a hypersensitivity to any ingredients contained in methylphenidate pharmaceuticals.
text: Because of possible hypertensive crisis, methylphenidate is contraindicated in patients being treated (currently or within the preceding 2 weeks) with non-selective, irreversible MAO-inhibitors (see section 4.3).